SII enrols 6000 subjects for efficacy trial of rBCG vaccine, VPM1002 against COVID-19 Press Information Bureau Jul 27, 2020 The DBT-BIRAC supported trial aims to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes…
